[1]陈云娥,李 璠,张子怡,等.营养支持治疗对终末期恶性肿瘤患者临床结局影响的Meta分析[J].医学信息,2019,(19):63-67.[doi:10.3969/j.issn.1006-1959.2019.19.019]
 CHEN Yun-e,LI Fan,ZHANG Zi-yi,et al.Meta-analysis of Effect of Nutritional Support Therapy on Clinical Outcome of Patients with Terminal-stage Malignant Tumor[J].Medical Information,2019,(19):63-67.[doi:10.3969/j.issn.1006-1959.2019.19.019]
点击复制

营养支持治疗对终末期恶性肿瘤患者临床结局影响的Meta分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2019年19期
页码:
63-67
栏目:
论著
出版日期:
2019-10-01

文章信息/Info

Title:
Meta-analysis of Effect of Nutritional Support Therapy on Clinical Outcome of Patients with Terminal-stage Malignant Tumor
文章编号:
1006-1959(2019)19-0063-05
作者:
陈云娥李 璠张子怡黄润青丁子航
(昆明医科大学药学院暨云南省天然药物药理重点实验室,云南 昆明 650500)
Author(s):
CHEN Yun-eLI FanZHANG Zi-yiHUANG Run-qingDING Zi-hang
(School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products,Kunming Medical University, Kunming 650500,Yunnan China)
关键词:
营养支持恶性肿瘤血清白蛋白
Keywords:
utritional supportMalignant tumorSerum albumin
分类号:
R730
DOI:
10.3969/j.issn.1006-1959.2019.19.019
文献标志码:
A
摘要:
目的 评价营养支持治疗对终末期恶性肿瘤患者临床结局的影响,为改善终末期恶性肿瘤患者生存质量提供一定的指导。方法 检索1995年1月1日~2019年4月31日Cochrane Library、PubMed、Embase、中国知网、万方数据库、维普数据库中关于营养支持治疗对终末期恶性肿瘤患者影响的随机对照试验(RCT)文献,实验组为常规抗肿瘤治疗加营养支持,对照组为常规抗肿瘤治疗和普通膳食,采用RevMan5.3软件进行统计分析,比较两组血清白蛋白(ALB)、血清前白蛋白(PA)、营养风险、不良反应。结果 本研究共纳入5篇文献、500例患者,Meta分析结果显示:实验组ALB高于对照组,差异有统计学意义(WMD=8.29,95%CI:4.84~11.74,P<0.05);实验组PA高于对照组,差异有统计学意义(WMD=58.54,95%CI:38.98~78.10,P<0.05)。对照组发生营养风险的可能性是实验组的2.75倍,差异有统计学意义(RR=2.75,95%CI:1.80~4.20,P<0.05);对照组发生不良反应的可能性是实验组的1.17倍,差异有统计学意义(RR=1.17,95%CI:1.02~1.34,P<0.05)。结论 合理的营养支持能明显改善终末期恶性肿瘤患者ALB、PA和降低营养风险及不良反应的发生。
Abstract:
Objective To evaluate the effect of nutritional support therapy on clinical outcomes in patients with end-stage malignant tumors, and to provide some guidance for improving the quality of life of patients with end-stage malignant tumors. Methods A randomized controlled trial (RCT) on the effects of nutritional support therapy on patients with end-stage malignancies from Cochrane Library, PubMed, Embase, CNKI, Wanfang Database, and VIP Database from January 1, 1995 to April 31, 2019. The literature, the experimental group for conventional anti-tumor treatment plus nutritional support, the control group for conventional anti-tumor treatment and common diet, using RevMan5.3 software for statistical analysis.Results A total of 5 articles and 500 patients were included in the study. Meta-analysis showed that serum albumin (ALB) was higher in the experimental group than in the control group (WMD=8.29, 95% CI: 4.84~11.74, P<0.05); serum prealbumin (PA) in the experimental group was higher than the control group, the difference was statistically significant (WMD=58.54, 95% CI: 38.98~78.10, P<0.05). The risk of nutritional risk in the control group was 2.75 times that of the experimental group,the difference was statistically significant (RR=2.75, 95% CI: 1.80~4.20, P<0.05); the possibility of adverse reactions in the control group was experimental group 1.17 times, the difference was statistically significant (RR=1.17, 95% CI: 1.02~1.34, P<0.05).Conclusion Rational nutritional support can significantly improve ALB, PA and reduce nutritional risk and adverse reactions in patients with end-stage malignant tumors.

参考文献/References:

[1]Bauer JD,Capra S.Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy-a pilot study[J].Support Care Cancer,2005,13(4):270-274. [2]杜金.癌症患者的临床营养支持治疗[J].吉林医学,2016,37(12):3023-3025. [3]高小荃,王林娟.终末期肿瘤患者接受护理干预对其生活质量的影响[J].结直肠肛门外科,2018,24(S1):96-97. [4]邹立新,张曙辉,吴剑雄.恶性肿瘤病人临终期营养支持治疗体会[J].中国卫生产业,2014(1):170-171. [5]张阳,汪雪,王肖蒙,等.营养支持护理和心理护理改善胃癌患者生活质量的效果观察[J].实用临床护理学电子杂志,2019, 4(6):38-39. [6]吴英韬,袁杰利.微生态制剂在肠内营养治疗的研究进展与应用[J].中国微生态学杂志,2012,24(10):943-947. [7]McClave SA,Taylor BE,Martindale RG,et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)[J].JPEN J Parenter Enteral Nutr,2016,40(2):159-211. [8]薛丹凤,李湘红,赵相军.肠内营养粉安素对终末期恶性肿瘤患者营养状况和糖脂代谢的影响[J].中国药业,2016,25(7):11-13. [9]薛丹凤,李湘红,李大鹏,等.营养支持治疗对终末期恶性肿瘤患者的临床应用价值[J].西部医学,2016,28(9):1282-1285. [10]车晓玲,翁美玲,邹燕.营养支持治疗对老年终末期恶性肿瘤患者营养状况、厌食行为及癌因性疲乏的影响[J].中国老年学杂志,2017,37(6):1430-1432. [11]方秀华,徐网兰,张秦.营养支持疗法在终末期恶性肿瘤患者中的应用价值分析[J].中国医刊,2019,54(4):448-451. [12]徐丹.终末期肿瘤合并恶液质患者营养支持治疗的疗效观察[J].世界最新医学信息文摘,2019,19(9):20-23. [13]Salani B,Del Rio A,Marini C,et al.Metformin,cancer and glucose metabolism[J].Endocr Relat Cancer,2014,21(6):R461-R471. [14]林在楷,殷保兵.中晚期肿瘤患者营养支持治疗的临床进展[J].上海医药,2015,36(4):3-6. [15]Flavahan WA,Wu Q,Hitomi M,et al.Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake[J].Nat Neurosci,2013,16(10):1373-1382. [16]Ma C,Tsai H,Su W,et al.Combination of arginine,glutamine,and omega-3 fatty acid supplements for perioperative enteral nutrition in surgical patients with gastric adenocarcinoma or gastrointestinal stromal tumor (GIST):a prospective,randomized,double-blind study[J].J Postgrad Med,2018,64(3):155-163. [17]Ose J,Fortner RT,Rinaldi S,et al.Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition[J].Int J Cancer,2015,136(2):399-410. [18]杨红,匡毅.恶性肿瘤患者营养支持的研究进展[J].中国误诊学杂志,2011,11(25):6082-6084. [19]Hasenberg T,Essenbreis M, Herold A, et al.Early supplementation of parenteral nutrition is capable of improving quality of life,chemotherapy-related toxicity and body composition in patients with advanced colorectal carcinoma undergoing palliative treatment: results from a prospective,randomized clinical trial[J].Colorectal Dis,2010,12(10 Online):e190-e199. [20]赵玉鹏.营养支持治疗在肿瘤内科治疗中的地位和作用分析[J].中国卫生标准管理,2015,6(3):139-140. [21]石汉平,许红霞,李苏宜,等.营养不良的五阶梯治疗[J].肿瘤代谢与营养电子杂志,2015,2(1):29-33. [22]余小冬,金晓燕.谷氨酰胺营养支持对胃肠道恶性肿瘤恶液质患者血清细胞因子水平的影响[J].中国中西医结合消化杂志,2018(4):364-366.

相似文献/References:

[1]袁东方,张刚刚.恶性肿瘤病历主要诊断选择思路分析[J].医学信息,2018,(07):28.[doi:10.3969/j.issn.1006-1959.2018.07.010]
 YUAN Dong-fang,ZHANG Gang-gang.Analysis of Main Diagnostic Options for Malignant Tumor Records[J].Medical Information,2018,(19):28.[doi:10.3969/j.issn.1006-1959.2018.07.010]
[2]何万伦,张薰月,陈 力.外科手术治疗食管异物研究[J].医学信息,2019,(04):171.[doi:10.3969/j.issn.1006-1959.2019.04.057]
 HE Wan-lun,ZHANG Xun-yue,CHEN Li.Surgical Treatment of Foreign Body in Esophagus[J].Medical Information,2019,(19):171.[doi:10.3969/j.issn.1006-1959.2019.04.057]
[3]刘 训,吴 春.儿童先天性心脏病围术期营养支持的研究[J].医学信息,2019,(09):21.[doi:10.3969/j.issn.1006-1959.2019.09.008]
 LIU Xun,WU Chun.Perioperative Nutritional Support in Children with Congenital Heart Disease[J].Medical Information,2019,(19):21.[doi:10.3969/j.issn.1006-1959.2019.09.008]
[4]何 静.上皮性卵巢癌化学治疗的研究[J].医学信息,2019,(18):24.[doi:10.3969/j.issn.1006-1959.2019.18.009]
 HE Jing.Chemotherapy of Epithelial Ovarian Cancer[J].Medical Information,2019,(19):24.[doi:10.3969/j.issn.1006-1959.2019.18.009]
[5]梁春玲,杨文珊.消化道恶性肿瘤的临床分析[J].医学信息,2019,(18):124.[doi:10.3969/j.issn.1006-1959.2019.18.041]
 LIANG Chun-ling,YANG Wen-shan.Clinical Analysis of Malignant Tumors of the Digestive Tract[J].Medical Information,2019,(19):124.[doi:10.3969/j.issn.1006-1959.2019.18.041]
[6]杜鑫荣.超声造影在肝实质性肿块诊断及鉴别中的临床价值[J].医学信息,2019,(19):176.[doi:10.3969/j.issn.1006-1959.2019.19.059]
 DU Xin-rong.Clinical Value of Contrast-enhanced Ultrasonography in the Diagnosis and Differential Diagnosis of Liver Mass[J].Medical Information,2019,(19):176.[doi:10.3969/j.issn.1006-1959.2019.19.059]
[7]姜天奇,张洪亮.原发性肝癌的中西医治疗现状[J].医学信息,2019,(13):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
 JIANG Tian-qi,ZHANG Hong-liang.Current Status of Treatment of Primary Liver Cancer with Traditional Chinese Medicine and Western Medicine[J].Medical Information,2019,(19):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]

更新日期/Last Update: 2019-10-01